statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bloomberg / Contributor / Getty Images

 Key TakeawaysBillionaire Stanley Druckenmiller added more than three dozen new positions to his portfolio in the first quarter, including Apple, Reddit...

Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake

Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today...

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

Latest Ratings for BCYC
 DateFirmActionFromTo Mar 2022JMP SecuritiesMaintainsMarket Outperform Feb 2022Morgan StanleyInitiates Coverage OnEqual-Weight Dec 2021SVB LeerinkInitiates Coverage...

Expert Ratings For Bicycle Therapeutics

Bicycle Therapeutics plc (NASDAQ:BCYC - Get Free Report) CEO Kevin Lee sold 3,158 shares of Bicycle Therapeutics stock in a transaction on Wednesday, April 3rd. The stock was sold at an average price...

Bicycle Therapeutics plc (NASDAQ:BCYC) CEO Kevin Lee Sells 3,158 Shares

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Bicycle Therapeutics plc (NASDAQ:BCYC  Get Free Report)s stock price dropped 3.1% during trading on Wednesday . The stock traded as low as $23.61 and last traded at $23.76...

Bicycle Therapeutics (NASDAQ:BCYC)  Shares Down 3.1%

This indicator may be signaling BCYC's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Bicycle Therapeutics plc (BCYC, $24.9) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

This indicator may be signaling that BCYC's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Bicycle Therapeutics plc (BCYC, $24.53) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024

Bicycle Therapeutics plc (BCYC, $25.57) entered Uptrend as Momentum indicator ascends above 0 level on Mar 20, 2024

This price move could be a signal that BCYC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

Bicycle Therapeutics (BCYC, $22.95) price may climb as it broke lower Bollinger Band on Mar 14, 2024

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Watchers	732
52-Wk Low	$12.54
52-Wk High	$28.91

Volume	124,459.00
52-Wk High	$28.91
52-Wk Low	$12.54

BCYC Bicycle Therapeutics Plc - ADR

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community